Hexaghen

Details

IGF-1 Optimizer

Ingredients

Hexaghen
[Patent Pending IGF-1 Complex Of: Ketonic Isomers(Cis And Trans-4 17(20)-Pregnadiene-316-Dione) GHRP-2 Hexapeptide Acetate]
Other Ingredients: Lactose Mannitol methylcarboxy cellulose Phosphatidyl Choline EDTA naturaland artificial citrus flavors Palmitic Acid Phosphatidyl Serine calcium carboxycellulose FD&C Red #40

Instructions

Take 30 minutes before bedtime. Place 2 Hexaghen tablets under your tongue and let dissolve completely then swallow. DO NOT EXCEED 2 TABLETS PER DAY.

Warnings

For healthy adults only. Do not exceed your recommended tablet dosage in a 12-hour period. Do not take more than 5 days per week. Do not take for more than 8 consecutive weeks. Maintain a level of good hydration while taking eNOXIDE.

NOT INTENDED FOR USE BY PERSONS WITH A MEDICAL CONDITION. NOT INTENDED FOR USE BY PERSONS UNDER AGE 18 OR PREGNANT OR LACTATING WOMEN.

Consult a physician or licensed qualified healthcare professional before using this product. Not for people with cardiovasculardiseases blood pressure problems head injury or other diseases or disorders. Consult your physician prior to use if you have a medical condition including but not limited to heart kidney liver or thyroid disease psychiatric or epileptic disorders difficulty urinating diabetes high or low blood pressure cardiac arrhythmia recurrent headaches enlarged prostate or glaucoma. Do not take with any medication especially cardiovascular and erectile dysfunction medications blood pressuredrugs heart or other cardiovascular system medications antibiotics antihistamines benzocaine and lidocaine or other drugs. Do not take with other supplement products designed to increase Nitric Oxide levels or products containing over 75 mg of niacin per serving or products containing yohimbine. Avoid alcohol consumption within 5 hours before and after taking eNOXIDE. Discontinue use immediately if you experience one or more of the following: dizziness light headedness severe headache low blood pressure rapid heartbeat shortness of breath.

Discontinue use 2 weeks prior to surgery. Do not use for more than 5 days per week or more than 8 consecutive weeks.